Ironwood Pharma (IRWD) Posts Narrower than Expected Q4 Loss

February 28, 2012 4:24 PM

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $32.15 million versus the consensus estimate of $24.05 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

No results found